ChinaBio Today -- Shengtai Pharmaceutical, Inc. reported disappointing results for its Q2, which ended December 31, 2008. The company recorded $14.8 million in revenue, a drop of 41%, because of a large decline in sales of its cornstarch business. Sales of its other major product, pharmaceutical grade glucose, actually climbed 13% to $9.3 million.
